{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:26:05Z","timestamp":1791595565593,"version":"4.3.4"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.juro.2018.03.135","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T16:31:37Z","timestamp":1523896297000},"page":"573-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer"],"prefix":"10.1097","volume":"200","author":[{"given":"Philipp","family":"Gild","sequence":"first","affiliation":[{"name":"Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Cole","sequence":"additional","affiliation":[{"name":"Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Krasnova","sequence":"additional","affiliation":[{"name":"Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra A.","family":"Dickerman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"von Landenberg","sequence":"additional","affiliation":[{"name":"Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei A.","family":"Mucci","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart R.","family":"Lipsitz","sequence":"additional","affiliation":[{"name":"Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix K.-H.","family":"Chun","sequence":"additional","affiliation":[{"name":"Department of Urology, University Hospital Frankfurt, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Kibel","sequence":"additional","affiliation":[{"name":"Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni K.","family":"Choueiri","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehzad","family":"Basaria","sequence":"additional","affiliation":[{"name":"Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc-Dien","family":"Trinh","sequence":"additional","affiliation":[{"name":"Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2018.03.135_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jnci\/djp404","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer","volume":"102","author":"Keating","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2018.03.135_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2018.03.135_bib3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.juro.2017.11.136","article-title":"Cognitive impairment in men with prostate cancer treated with androgen deprivation therapy: a systematic review and meta-analysis","volume":"199","author":"Sun","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.03.135_bib4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"suppl.","key":"10.1016\/j.juro.2018.03.135_bib5","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.juro.2018.03.135_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-230X-12-69","article-title":"A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.juro.2018.03.135_bib7","article-title":"Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction","volume":"30","author":"Traish","year":"2017","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.juro.2018.03.135_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.urolonc.2017.08.008","article-title":"Secondary data sources for health services research in urologic oncology","volume":"36","author":"Cole","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2018.03.135_bib9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.juro.2018.03.135_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bju.13203","article-title":"Dose-dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events","volume":"118","author":"Schmid","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2018.03.135_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: risk stratification, shared decision making, and care options","volume":"199","author":"Sanda","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.03.135_bib12","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2018.03.135_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/annonc\/mdx744","article-title":"Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer","volume":"29","author":"Yang","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.juro.2018.03.135_bib14","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/jama.296.22.2683","article-title":"Survival associated with treatment vs observation of localized prostate cancer in elderly men","volume":"296","author":"Wong","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2018.03.135_bib15","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.juro.2018.03.135_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","article-title":"Reducing bias in observational studies using subclassification on the propensity score","volume":"79","author":"Rosenbaum","year":"1984","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.juro.2018.03.135_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MOU.0000000000000407","article-title":"Secondary data analysis: techniques for comparing interventions and their limitations","volume":"27","author":"Cole","year":"2017","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.juro.2018.03.135_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/jgh.12106","article-title":"Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups","volume":"28","author":"Smits","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.juro.2018.03.135_bib19","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ejso.2015.06.011","article-title":"Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged >\/=66 years","volume":"41","author":"Abdollah","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.juro.2018.03.135_bib20","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/01.ju.0000127740.96006.1a","article-title":"Changing patterns in competing causes of death in men with prostate cancer: a population based study","volume":"171","author":"Lu-Yao","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2018.03.135_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2004","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.juro.2018.03.135_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-12-0525","article-title":"Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial","volume":"167","author":"Hoyos","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.juro.2018.03.135_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jamaoncol.2015.4917","article-title":"Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy","volume":"2","author":"Sun","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.juro.2018.03.135_bib24","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jc.2007-2595","article-title":"Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis","volume":"93","author":"Shahani","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2018.03.135_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.juro.2018.03.135_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.mcg.0000225583.32588.5e","article-title":"Nonalcoholic fatty liver disease induced by leuprorelin acetate","volume":"42","author":"Gabbi","year":"2008","journal-title":"J Clin Gastroenterol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718429849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718429849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2018.03.135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:48:22Z","timestamp":1651211302000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2018.03.135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1016\/j.juro.2018.03.135"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2018.03.135","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2018.03.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}